Literature DB >> 207436

Formation of Okazaki fragments in polyoma DNA synthesis caused by misincorporation of uracil.

K Brynolf, R Eliasson, P Reichard.   

Abstract

When dUTP replaced dTTP during polyoma DNA replication in isolated cell nuclei, radioactivity from labeled deoxynucleoside triphosphates was almost exclusively recovered in very short Okazaki fragments and incorporation ceased after a short time. Addition of uracil, a known inhibitor of the enzyme uracil-DNA glycosidase (Lindahl et al., 1977), increased total synthesis and shifted the incorporation to longer progeny strands. The presence of as little as 2.5% of dUTP in a dTTP-containing system gave a distinct increase in isotope incorporation into Okazaki pieces accompanied by a corresponding decrease in longer strands. This effect was reversed completely by uracil. The short strands formed from dUTP could be chased efficiently into long strands. Our results suggest that dUTP can be incorporated in place of dTTP into polyoma DNA, and that polyoma-infected nuclei, similar to E. coli (Tye et al., 1977), contain an excision-repair system which by removal of uracil causes strand breakage and under certain circumstances may contribute to the formation of Okazaki fragments.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207436     DOI: 10.1016/0092-8674(78)90330-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Identification of a prototypical single-stranded uracil DNA glycosylase from Listeria innocua.

Authors:  Jing Li; Ye Yang; Jose Guevara; Liangjiang Wang; Weiguo Cao
Journal:  DNA Repair (Amst)       Date:  2017-07-08

2.  The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence (TGACGTCA) is reduced by the misincorporation of U and increased by the deamination of C.

Authors:  A Verri; P Mazzarello; G Biamonti; S Spadari; F Focher
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Uracil-DNA glycosylase defective mutants of Ustilago maydis.

Authors:  Y Yamamoto; R Holliday
Journal:  Curr Genet       Date:  1983-07       Impact factor: 3.886

4.  Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase.

Authors:  Edward M Kennedy; Waaqo Daddacha; Rebecca Slater; Christina Gavegnano; Emilie Fromentin; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

5.  Study of human chromosome V. The effects of thymidine concentration and timing on the expression of uridine-induced constitutive fragile sites.

Authors:  S J Lin; C Figueiredo; L J Sciorra; M L Lee
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

6.  Discontinuous synthesis of both strands at the growing fork during polyoma DNA replication in vitro.

Authors:  M Närkhammar-Meuth; R Eliasson; G Magnusson
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

7.  Enzymatic degradation of uracil-containing deoxyribonucleic acid. V. Survival of Escherichia coli and coliphages treated with sodium bisulfite.

Authors:  R R Simmons; E C Friedberg
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

8.  Cell cycle regulation and in vitro hybrid arrest analysis of the major human uracil-DNA glycosylase.

Authors:  G Slupphaug; L C Olsen; D Helland; R Aasland; H E Krokan
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

9.  Uracil DNa-glycosylase from HeLa cells: general properties, substrate specificity and effect of uracil analogs.

Authors:  H Krokan; C U Wittwer
Journal:  Nucleic Acids Res       Date:  1981-06-11       Impact factor: 16.971

10.  Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration.

Authors:  Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.